Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
In a landmark verdict, the Brazilian Supreme Federal Court, that country’s highest judicial authority, on 11 September convicted former president...
Read moreDetails
An American scholar has written a book in which he tries to explain China’s recent rise. Dan Wang’s thesis is...
Read moreDetails
India’s top anti-corruption watchdog, the CVC, has just delivered a stinging reality check to the CBI, and it’s not a...
Read moreDetails
The memories of the deadly al-Qaeda strikes on 9/11 on iconic US building complexes are still alive even after several...
Read moreDetails